Post by Clario

Reliable cardiac safety assessment is foundational to confident clinical development decisions.   From first‑in‑human dose escalation through late‑phase confirmatory studies, sponsors need ECG data that is clean and interpretable to support both patient safety and regulatory review.   In this article, Vickas Patel, M.D., Ph.D., VP and Chief Medical Officer, Cardiology, outlines how centralized digital ECGs can help reduce variability, support standardized data collection, and improve consistency across studies.   🔗 Read more about the benefits of leveraging centralized digital ECGs in clinical trials: https://lnkd.in/esWfVhMy   #ClinicalTrials #CardiacSafety